DEEPNOID Toekomstige groei
Future criteriumcontroles 3/6
DEEPNOID is forecast to grow revenue at 61.9% per annum.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
Healthcare Services winstgroei | 29.1% |
Inkomstengroei | 61.9% |
Toekomstig rendement op eigen vermogen | 32.2% |
Dekking van analisten | Low |
Laatst bijgewerkt | 07 Jun 2024 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 41,300 | N/A | N/A | N/A | 1 |
12/31/2025 | 30,200 | N/A | N/A | N/A | 1 |
12/31/2024 | 14,600 | N/A | N/A | N/A | 1 |
6/30/2024 | 5,796 | -7,978 | -14,282 | -12,863 | N/A |
3/31/2024 | 2,130 | -7,255 | -8,760 | -7,378 | N/A |
12/31/2023 | 1,933 | -6,737 | -5,587 | -4,772 | N/A |
9/30/2023 | 2,809 | -5,868 | -5,461 | -4,904 | N/A |
6/30/2023 | 3,238 | -5,325 | -5,654 | -5,154 | N/A |
3/31/2023 | 3,199 | -4,901 | -4,757 | -4,316 | N/A |
12/31/2022 | 3,182 | -5,334 | -4,234 | -3,707 | N/A |
9/30/2022 | 1,446 | -6,890 | -5,934 | -5,406 | N/A |
6/30/2022 | 1,138 | -5,991 | -6,001 | -4,900 | N/A |
3/31/2022 | 1,053 | -9,258 | -6,196 | -5,013 | N/A |
12/31/2021 | 944 | -8,854 | -5,912 | -4,612 | N/A |
9/30/2021 | 1,082 | -10,802 | -6,513 | -5,142 | N/A |
3/31/2021 | 656 | -12,974 | -5,215 | -4,406 | N/A |
12/31/2020 | 1,040 | -13,600 | -4,069 | -3,496 | N/A |
12/31/2019 | 235 | -8,715 | -2,614 | -2,175 | N/A |
12/31/2018 | 887 | -1,583 | -1,920 | -1,815 | N/A |
12/31/2017 | 1,431 | -1,345 | N/A | -1,409 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if A315640's forecast earnings growth is above the savings rate (2.6%).
Winst versus markt: Insufficient data to determine if A315640's earnings are forecast to grow faster than the KR market
Hoge groeiwinsten: Insufficient data to determine if A315640's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: A315640's revenue (61.9% per year) is forecast to grow faster than the KR market (9.9% per year).
Hoge groei-inkomsten: A315640's revenue (61.9% per year) is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: A315640's Return on Equity is forecast to be high in 3 years time (32.2%)